Target intelligence / Profile preview

Trypanosomal kinetoplast DNA (kDNA)

Target
kDNA
Molecular classification
Nucleic acid, Mitochondrial DNA
01

Overview

Trypanosomal kinetoplast DNA (kDNA) is a unique and complex mitochondrial genome structure found in kinetoplastid protozoa, such as Trypanosoma and Leishmania species (Jensen & Englund, 1998, Cell). It consists of a massive, catenated network of thousands of circular DNA molecules, categorized into maxicircles and minicircles (Shapiro & Englund, 1995, Annu Rev Microbiol). Maxicircles encode essential components of the mitochondrial respiratory chain, while minicircles encode guide RNAs necessary for the extensive RNA editing of maxicircle transcripts (Stuart et al., 2005, Science). Because this structure is absent in mammalian cells, it serves as a highly specific therapeutic target for antiparasitic agents (D'Ambrosio et al., 2016, Molecules). Drugs like pentamidine and diminazene target kDNA by binding to its minor groove, particularly in AT-rich regions, which interferes with DNA replication and the activity of mitochondrial topoisomerases (Wilson et al., 2008, Curr Med Chem). This disruption leads to the loss of the kDNA network, a condition known as dyskinetoplasty, which ultimately results in parasite death due to the failure of mitochondrial energy metabolism (Schnaufer et al., 2002, Science).

Other names
Kinetoplast DNAMitochondrial DNA of trypanosomatidskDNA networkKinetoplast mitochondrial DNA
02

Mechanism of action

Drugs typically bind to the minor groove of AT-rich regions or intercalate into the DNA, leading to the inhibition of mitochondrial topoisomerases, disruption of the catenated network structure, and eventual loss of mitochondrial function (Wilson et al., 2008, Curr Med Chem).

03

Biological functions

Mitochondrial genome maintenanceRNA editingProtein synthesisReplicationTranscription
04

Disease associations

African trypanosomiasisChagas diseaseLeishmaniasisInfection
05

Safety considerations

NephrotoxicityHepatotoxicityInjection site reactionsDevelopment of drug resistanceSystemic toxicity due to off-target effects of diamidines
06

Interacting drugs

Pentamidine

6 more in the full profile.

07

Biomarkers

kDNA minicircle PCRkDNA maxicircle detectionDyskinetoplasty (loss of kDNA)

Beyond the preview

Go deeper on Trypanosomal kinetoplast DNA (kDNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trypanosomal kinetoplast DNA (kDNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call